Suppliers / Yung Shin Pharm. Ind

Yung Shin Pharm. Ind

Taiwan Updated 9 July 2026

The public registers hold a second record for Yung Shin Pharm. Ind. The fuller profile, with 12 active US DMFs and 0 valid CEPs, is at Yung Shin Pharmaceutical. Figures on this page cover only this record.

Yung Shin Pharm. Ind is a finished-dose manufacturer based in Taiwan. It appears in 1 regulatory filing across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 22 October 2019 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 22 October 2019 VAI US FDA
  • 27 July 2018 VAI US FDA
  • 8 May 2014 NAI US FDA
  • 16 August 2013 NAI US FDA
  • 30 April 2012 VAI US FDA
  • 5 February 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Taiwan, Taiwan 3002808536
Tachia, Taiwan Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 1 None
EMA None 1

Questions about Yung Shin Pharm. Ind

Does Yung Shin Pharm. Ind hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Yung Shin Pharm. Ind. It does have 1 filing with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Is Yung Shin Pharm. Ind FDA-registered?
One site operated by Yung Shin Pharm. Ind carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Yung Shin Pharm. Ind's last inspection go?
The most recent inspection on record closed on 22 October 2019 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 6 inspections are on file.
Where does Yung Shin Pharm. Ind manufacture?
2 registered sites are on record, in Taiwan (Taiwan and Tachia). Every site is listed on this page with the register it came from.
Which regulators recognise Yung Shin Pharm. Ind's GMP?
Current GMP certificates are on record from EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Yung Shin Pharm. Ind comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 22 October 2019.

Comparable suppliers

Bora Pharmaceutical Laboratories also in Taiwan Bora Pharmaceuticals also in Taiwan Lotus Pharmaceutical Co Ltd Nantou Plant also in Taiwan Lotus Pharmaceutical also in Taiwan Nang Kuang Pharmaceutical also in Taiwan

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates